The peptidylarginine deiminase (PAD)-mediated pathway of EV biogenesis has been highlighted as a novel and significant contributor to EV release in a range of cancer cells [8,9,33,36], including most recently in GBM by our group [9]. Here, PADI4 is linked to glioblastoma.